We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 26 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Aug 13, 2025～Sep 09, 2025
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Aug 13, 2025～Sep 09, 2025
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. 関東化学株式会社 Tokyo//Chemical バイオケミカル部
  3. null/null
  4. 4 キャタレント・ジャパン Tokyo//Manufacturing and processing contract
  5. 5 カツマタ Shizuoka//Medical and Welfare 医薬品製造販売部
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Aug 13, 2025～Sep 09, 2025
This ranking is based on the number of page views on our site.

  1. For various titrations! The titration "indicator" specified in JIS K8001. 関東化学株式会社 バイオケミカル部
  2. Development of various types of medium-sized molecule (nucleic acid, peptide) pharmaceuticals (processes, analytical methods, etc.)
  3. Global Procurement of Reference Drugs <From Drug Procurement to Problem Solving> キャタレント・ジャパン
  4. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  5. 4 Pharmaceutical CDMO services 大塚化学

medicine Product List

271～285 item / All 516 items

Displayed results
[Research Material] The Global Market for Jet Lag Treatment

[Research Material] The Global Market for Jet Lag Treatment

Global Market for Jet Lag Treatment: Prescription, OTC, Hospital Pharmacies, Retail Pharmacies, Online

This research report (Global Jet Lag Treatment Market) investigates and analyzes the current status and outlook for the global jet lag treatment market over the next five years. It includes information on the overview of the global jet lag treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the jet lag treatment market focus on prescription and OTC, while the segments by application target hospital pharmacies, retail pharmacies, and online sales. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for jet lag treatment. It also includes the market share of major companies in jet lag treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Secondary Progressive Multiple Sclerosis

[Research Material] Global Market for Treatment of Secondary Progressive Multiple Sclerosis

World Market for Treatment of Secondary Progressive Multiple Sclerosis: Inebilizumab, GLX-1112, DC-TAB, Etomoxir, IB-MS, and others...

This research report (Global Secondary Progressive Multiple Sclerosis Drug Market) investigates and analyzes the current state and outlook for the global market of secondary progressive multiple sclerosis treatment drugs over the next five years. It includes information on the overview of the global secondary progressive multiple sclerosis treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Inebilizumab, GLX-1112, DC-TAB, Etomoxir, IB-MS, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for secondary progressive multiple sclerosis treatment drugs. It also includes the market share of major companies in the secondary progressive multiple sclerosis treatment drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Drugs for Chemotherapy-Induced Nausea and Vomiting (CINV)

[Research Material] Global Market for Drugs for Chemotherapy-Induced Nausea and Vomiting (CINV)

World Market for Chemotherapy-Induced Nausea and Vomiting (CINV) Drugs: 5-HT3 Inhibitors, NK1 Inhibitors, Others, Highly Emetogenic Chemotherapy, Moderately Emetogenic Chemotherapy ...

This research report (Global Chemotherapy Induced Nausea and Vomiting (C)) investigates and analyzes the current status and outlook for the global market of drugs for chemotherapy-induced nausea and vomiting (CINV) over the next five years. It includes information on the global overview of the chemotherapy-induced nausea and vomiting (CINV) drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for chemotherapy-induced nausea and vomiting (CINV) drugs by type include 5-HT3 antagonists, NK1 antagonists, and others, while the segments by application cover highly emetogenic chemotherapy, moderately emetogenic chemotherapy, low emetogenic chemotherapy, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for chemotherapy-induced nausea and vomiting (CINV) drugs. It also includes the market share of major companies in the chemotherapy-induced nausea and vomiting (CINV) drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Head and Neck Cancer Treatments

[Research Material] Global Market for Head and Neck Cancer Treatments

Global Market for Head and Neck Cancer Treatments: PD Inhibitors, Microtubule Inhibitors, EGFR Inhibitors, Surgery, Radiation Therapy, Chemotherapy, Immunotherapy

This research report (Global Head and Neck Cancer Therapeutics Market) investigates and analyzes the current state and outlook for the global market for head and neck cancer therapeutics over the next five years. It includes information on the overview of the global head and neck cancer therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include PD inhibitors, microtubule inhibitors, and EGFR inhibitors, while the segments by application focus on surgery, radiation therapy, chemotherapy, and immunotherapy. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for head and neck cancer therapeutics. It also includes the market share of major companies in head and neck cancer therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Gestational Diabetes Treatment

[Research Material] The Global Market for Gestational Diabetes Treatment

Global Market for Gestational Diabetes Treatment: Insulin, SGLT-2 Inhibitors, Alpha-Glucosidase Inhibitors, Others, Hospital Pharmacies, Retail Pharmacies, etc.

This research report (Global Gestational Diabetes Treatment Market) investigates and analyzes the current state and future outlook of the global market for gestational diabetes treatment over the next five years. It includes information on the overview of the global gestational diabetes treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the gestational diabetes treatment market include insulin, SGLT-2 inhibitors, alpha-glucosidase inhibitors, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for gestational diabetes treatment. It also includes the market share of major companies in gestational diabetes treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] World Market for Ear Infection Treatment

[Research Material] World Market for Ear Infection Treatment

Global Market for Ear Infection Treatment: Surgery, Medications, Others, Hospitals, Clinics, Others

This research report (Global Ear Infection Treatment Market) investigates and analyzes the current state and outlook for the global ear infection treatment market over the next five years. It includes information on the overview of the global ear infection treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the ear infection treatment market include surgery, medication, and others, while the segments by application include hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for ear infection treatment. The report also includes the market share of major companies in ear infection treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Antiviral Treatments

[Research Material] Global Market for Antiviral Treatments

Global Market for Antiviral Treatments: Herpes Antiviral Drugs, Hepatitis Antiviral Drugs, HIV Antiviral Drugs, Influenza Antiviral Drugs, Others ...

This research report (Global Antiviral Therapeutics Market) investigates and analyzes the current state of the global antiviral therapeutics market and its outlook for the next five years. It includes information on the overview of the global antiviral therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the antiviral therapeutics market include herpes antivirals, hepatitis antivirals, HIV antivirals, influenza antivirals, and others, while the segments by application cover hospitals, clinics, outpatient surgery centers, pharmacies, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for antiviral therapeutics. The report also includes the market share of major companies in antiviral therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Hemophilia Treatment

[Market Report] Global Market for Hemophilia Treatment

World Market for Hemophilia Treatment: Advances in medical therapies that enhance patient quality of life in the management of this rare bleeding disorder.

The global hemophilia treatment market is making significant progress as advancements in medical therapies innovate the management of this rare bleeding disorder. Hemophilia is a condition caused by genetic factors that impairs the blood's ability to clot properly, leading to prolonged bleeding times and an increased risk of severe bleeding symptoms. However, the emergence of innovative treatments has allowed patients to experience improved outcomes and enhanced quality of life. According to the latest market report, the global hemophilia treatment market reached $12.8 billion in 2021, with a steady growth forecast of a compound annual growth rate (CAGR) of 6.3% from 2022 to 2030. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] The Global Market for Erectile Dysfunction

[Market Report] The Global Market for Erectile Dysfunction

The global erectile dysfunction market is expected to enhance men's health and show significant growth.

The global erectile dysfunction (ED) market is focused on enhancing men's health and well-being, recording approximately $2.3 billion in sales in 2022. With a promise to address critical aspects of men's health, industry experts predict that this market will achieve an estimated revenue of $4.7 billion by 2031. This anticipated surge highlights a significant compound annual growth rate (CAGR) of 8.5% during the forecast period from 2023 to 2031. Erectile dysfunction is a symptom that affects the quality of life for men and is a significant concern for both individuals and the medical community. The global ED market serves as a beacon of hope for men seeking effective solutions to restore confidence, intimacy, and overall well-being. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Gabapentin

[Market Report] Global Market for Gabapentin

The global market for Gabapentin is thriving, expected to reach 292 million USD by 2031.

The global gabapentin market has experienced significant growth, with sales surging to approximately $1.9816 billion in 2022. This upward trend is expected to continue, with a projected compound annual growth rate (CAGR) of 4.37% during the forecast period from 2023 to 2031, reaching an estimated $2.912 billion by 2031. Gabapentin, a widely used medication, has garnered considerable attention in the healthcare sector due to its effectiveness in treating various conditions. It belongs to the class of anticonvulsants and is primarily prescribed for the management of epilepsy and neuropathic pain. In addition to these uses, gabapentin has also been recognized for its utility in treating anxiety disorders, restless legs syndrome, and as an adjunct therapy for individuals suffering from opioid withdrawal. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Heart Failure Treatment Drugs

[Market Report] Global Market for Heart Failure Treatment Drugs

The global market for heart failure treatment drugs is expected to exceed 49.6 billion USD by 2031.

The global heart failure treatment drug market is on an upward trend, with revenues projected to reach $49.6 billion by 2031. This significant growth, driven by an attractive compound annual growth rate (CAGR) of 9.43% from 2023 to 2031, underscores the urgent need for advanced treatments and therapies to combat heart failure. The growth forecast for the global heart failure treatment drug market reflects ongoing efforts to improve the quality of life for individuals suffering from heart failure. As medicine advances and new treatments emerge, the outlook for heart failure patients is becoming increasingly optimistic. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Skin Cancer Treatment

[Market Report] Global Market for Skin Cancer Treatment

The global market for skin cancer treatment is rapidly expanding and is expected to reach 14.5 billion USD by 2031.

As the battle against skin cancer, one of the most common cancers, continues, the global skin cancer treatment market is emerging as a bastion of hope. This market recorded a solid revenue of approximately 7.72 billion USD in 2022 and is expected to achieve a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2023 to 2031, indicating remarkable growth. By 2031, it is projected to reach an astonishing valuation of 14.5 billion USD. Skin cancer is often caused by excessive sunbathing and ultraviolet rays, and there is growing global concern about it. The rising incidence of skin cancer and increasing awareness of the importance of early diagnosis and treatment are driving demand for advanced and effective skin cancer treatment options. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] The Global Market for Oral Ulcer Treatment

[Market Report] The Global Market for Oral Ulcer Treatment

The global market for oral mucositis treatment is projected to reach 1.92 billion dollars by 2031.

The global oral ulcer treatment market, which achieved sales of 1.34 billion USD in 2022, is steadily growing and is projected to reach 1.92 billion USD by 2031. This growth is progressing at a compound annual growth rate (CAGR) of 4.1% from 2023 to 2031, reflecting the increasing demand for effective treatments for this common oral condition. Oral ulcers are characterized by painful sores or lesions on the oral mucosa, significantly impacting an individual's quality of life (QOL). These ulcers can appear on the cheeks, lips, tongue, gums, the roof and floor of the mouth, and sometimes even the esophagus. Generally, oral ulcers present as lesions with a red outer ring and a pale or yellow center, causing discomfort or pain, especially during eating and drinking. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Inflammatory Bowel Disease Treatment Market

[Market Report] Global Inflammatory Bowel Disease Treatment Market

The global inflammatory bowel disease treatment market is expected to achieve steady growth, reaching 34 billion USD by 2031.

The global inflammatory bowel disease (IBD) treatment market is on an upward trajectory, with revenues reaching approximately $22 billion in 2022, and an estimated value of $34 billion by 2031. This significant growth is projected to occur at a compound annual growth rate (CAGR) of 5.1% during the forecast period from 2023 to 2031. Inflammatory bowel disease (IBD) is a chronic condition characterized by inflammation of the gastrointestinal tract. It primarily consists of two distinct conditions: Crohn's disease and ulcerative colitis. Crohn's disease is known for causing inflammation and discomfort in various parts of the gastrointestinal tract, often affecting the small intestine and the upper part of the large intestine. On the other hand, ulcerative colitis primarily causes pain and inflammation in the colon. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Schizophrenia Treatment Drug Market

[Market Report] Global Schizophrenia Treatment Drug Market

The global schizophrenia treatment market is expected to reach 12.57 billion USD by 2031, aiming for steady growth.

The global schizophrenia treatment market is experiencing steady growth, with total revenue reaching approximately $7.57 billion in 2022. Furthermore, it is estimated to rise to $12.57 billion by 2031, corresponding to a compound annual growth rate (CAGR) of 5.8% from 2020. The forecast period is from 2023 to 2031. Schizophrenia is characterized by its chronic and severe nature, significantly impacting an individual's behavior, thinking, perception of reality, emotional expression, and interpersonal relationships. Although schizophrenia is not as common as other severe mental disorders, it remains one of the most persistent and debilitating mental illnesses. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.